Answers are grounded in this paper and cite their sources.
This Clinical Implementation White Paper provides guidance on managing myopia progression in children using RLRL therapy, highlighting safety and efficacy.
This Clinical Implementation White Paper establishes a structured, physician-supervised, and safety-controlled clinical framework for the management of myopia progression in Polish children and adolescents utilizing Repeated Low-Level Red-Light (RLRL) therapy. Grounded in recent clinical trial data and international expert consensus, this position paper outlines standardized treatment protocols, rigorous patient selection criteria (including absolute and relative contraindications), and mandatory safety monitoring procedures to mitigate risks such as retinal phototoxicity. Designed for ophthalmologists, optometrists, and clinical practitioners, the document provides actionable guidance for the integration of RLRL therapy into domestic pediatric ophthalmic care, ensuring the highest standards of safety, efficacy, and collaborative clinical pathways.
No takes yet. Share an insight, caveat, or question.
Michał Szymon Nowak (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: